140 related articles for article (PubMed ID: 15516845)
1. A636P testing in Ashkenazi Jews.
Guillem JG; Moore HG; Palmer C; Glogowski E; Finch R; Nafa K; Markowitz AJ; Offit K; Ellis NA
Fam Cancer; 2004; 3(3-4):223-7. PubMed ID: 15516845
[TBL] [Abstract][Full Text] [Related]
2. Single-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical management.
Guillem JG; Glogowski E; Moore HG; Nafa K; Markowitz AJ; Shia J; Offit K; Ellis NA
Ann Surg; 2007 Apr; 245(4):560-5. PubMed ID: 17414604
[TBL] [Abstract][Full Text] [Related]
3. A636P is associated with early-onset colon cancer in Ashkenazi Jews.
Guillem JG; Rapaport BS; Kirchhoff T; Kolachana P; Nafa K; Glogowski E; Finch R; Huang H; Foulkes WD; Markowitz A; Ellis NA; Offit K
J Am Coll Surg; 2003 Feb; 196(2):222-5. PubMed ID: 12595050
[TBL] [Abstract][Full Text] [Related]
4. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.
Foulkes WD; Thiffault I; Gruber SB; Horwitz M; Hamel N; Lee C; Shia J; Markowitz A; Figer A; Friedman E; Farber D; Greenwood CM; Bonner JD; Nafa K; Walsh T; Marcus V; Tomsho L; Gebert J; Macrae FA; Gaff CL; Paillerets BB; Gregersen PK; Weitzel JN; Gordon PH; MacNamara E; King MC; Hampel H; De La Chapelle A; Boyd J; Offit K; Rennert G; Chong G; Ellis NA
Am J Hum Genet; 2002 Dec; 71(6):1395-412. PubMed ID: 12454801
[TBL] [Abstract][Full Text] [Related]
5. Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation.
Lavie O; Gruber SB; Lejbkowicz F; Dishon S; Rennert G
Am J Obstet Gynecol; 2008 Aug; 199(2):148.e1-3. PubMed ID: 18674656
[TBL] [Abstract][Full Text] [Related]
6. The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer.
Laitman Y; Herskovitz L; Golan T; Kaufman B; Paluch SS; Friedman E
Fam Cancer; 2012 Jun; 11(2):243-7. PubMed ID: 22219001
[TBL] [Abstract][Full Text] [Related]
7. Genetic analyses in consecutive israeli jewish colorectal cancer patients.
Fidder HH; Figer A; Geva R; Flex D; Schayek H; Avidan B; Meir SB; Friedman E
Am J Gastroenterol; 2005 Jun; 100(6):1376-80. PubMed ID: 15929773
[TBL] [Abstract][Full Text] [Related]
8. High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation.
Mukherjee B; Rennert G; Ahn J; Dishon S; Lejbkowicz F; Rennert HS; Shiovitz S; Moreno V; Gruber SB
Gastroenterology; 2011 Jun; 140(7):1919-26. PubMed ID: 21419771
[TBL] [Abstract][Full Text] [Related]
9. Genetic testing for hereditary nonpolyposis colorectal cancer.
Hoedema R; Monroe T; Bos C; Palmer S; Kim D; Marvin M; Luchtefeld M
Am Surg; 2003 May; 69(5):387-91; discussion 391-2. PubMed ID: 12769209
[TBL] [Abstract][Full Text] [Related]
10. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
11. Lynch Syndrome in high risk Ashkenazi Jews in Israel.
Goldberg Y; Kedar I; Kariiv R; Halpern N; Plesser M; Hubert A; Kaduri L; Sagi M; Lerer I; Abeliovich D; Hamburger T; Nissan A; Goldshmidt H; Solar I; Geva R; Strul H; Rosner G; Baris H; Levi Z; Peretz T
Fam Cancer; 2014 Mar; 13(1):65-73. PubMed ID: 23990280
[TBL] [Abstract][Full Text] [Related]
12. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.
Piñol V; Castells A; Andreu M; Castellví-Bel S; Alenda C; Llor X; Xicola RM; Rodríguez-Moranta F; Payá A; Jover R; Bessa X;
JAMA; 2005 Apr; 293(16):1986-94. PubMed ID: 15855432
[TBL] [Abstract][Full Text] [Related]
14. Identification of germline genetic mutations in patients with pancreatic cancer.
Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
[TBL] [Abstract][Full Text] [Related]
15. Novel MLH1 and MSH2 germline mutations in the first HNPCC families identified in Slovakia.
Bartosova Z; Fridrichova I; Bujalkova M; Wolf B; Ilencikova D; Krizan P; Hlavcak P; Palaj J; Lukac L; Lukacova M; Böör A; Haider R; Jiricny J; Nyström-Lahti M; Marra G
Hum Mutat; 2003 Apr; 21(4):449. PubMed ID: 12655568
[TBL] [Abstract][Full Text] [Related]
16. Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene.
Lage PA; Albuquerque C; Sousa RG; Cravo ML; Salazar M; Francisco I; Maia L; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo PA; Nobre-Leitão C
Cancer; 2004 Jul; 101(1):172-7. PubMed ID: 15222003
[TBL] [Abstract][Full Text] [Related]
17. The HNPCC associated MSH2*1906G-->C founder mutation probably originated between 1440 CE and 1715 CE in the Ashkenazi Jewish population.
Sun S; Greenwood CM; Thiffault I; Hamel N; Chong G; Foulkes WD
J Med Genet; 2005 Oct; 42(10):766-8. PubMed ID: 16199548
[TBL] [Abstract][Full Text] [Related]
18. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.
Vasen HF; Stormorken A; Menko FH; Nagengast FM; Kleibeuker JH; Griffioen G; Taal BG; Moller P; Wijnen JT
J Clin Oncol; 2001 Oct; 19(20):4074-80. PubMed ID: 11600610
[TBL] [Abstract][Full Text] [Related]
19. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.
Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R
N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044
[TBL] [Abstract][Full Text] [Related]
20. An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC.
Goldberg Y; Porat RM; Kedar I; Shochat C; Galinsky D; Hamburger T; Hubert A; Strul H; Kariiv R; Ben-Avi L; Savion M; Pikarsky E; Abeliovich D; Bercovich D; Lerer I; Peretz T
Fam Cancer; 2010 Jun; 9(2):141-50. PubMed ID: 19851887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
